Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06840899
PHASE2
CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury
Sponsor: University of Wisconsin, Madison
View on ClinicalTrials.gov
Summary
The goal of this feasibility study is to learn whether Cannabidiol (CBD) can improve urinary incontinence and other symptoms in people with recent spinal cord injury (SCI). Participants will take Epidiolex (purified CBD) for 90 days
Official title: Cannabinoid Modulation for Neurogenic Lower Urinary Tract Dysfunction in Spinal Cord Injury
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-02-13
Completion Date
2027-05
Last Updated
2026-03-04
Healthy Volunteers
No
Interventions
DRUG
CBD
Twice daily 100mg cannabidiol (CBD)
Locations (1)
University of Wisconsin - Madison
Madison, Wisconsin, United States